Testiphenon
Alternative Names: TestifenonLatest Information Update: 18 Jan 2001
Price :
$50 *
At a glance
- Originator Nonindustrial source
- Class Antineoplastics
- Mechanism of Action Alkylating agents; Testosterone congener stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 18 Jan 2001 No-Development-Reported for Cancer in Russia (Unknown route)
- 15 Jul 1998 Profile reviewed
- 11 May 1995 Investigation in Cancer in Russia (Unknown route)